% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mor_ze mor_ze Dec 19, 2012 6:12 PM Flag

    Amicus said it expects to report results from 12 months of treatment in the first half of 2013, after which it plans to meet with the FDA to discuss a U.S. "approval pathway."

    FDA could approve this drug or not. It means nothing for shareholders as there is no substantial market for this drug. FOLD got a pipeline of drugs which can not be commercially viable no matter how much they would charge for treatment $5, $50 or $500

7.08+0.02(+0.28%)May 31 4:00 PMEDT